ID: ALA5272239

Max Phase: Preclinical

Molecular Formula: C18H13N5O

Molecular Weight: 315.34

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccccc1)c1cnn2ccc(-c3ccccn3)nc12

Standard InChI:  InChI=1S/C18H13N5O/c24-18(21-13-6-2-1-3-7-13)14-12-20-23-11-9-16(22-17(14)23)15-8-4-5-10-19-15/h1-12H,(H,21,24)

Standard InChI Key:  FXEROYMFKMMOMC-UHFFFAOYSA-N

Associated Targets(non-human)

Salmonella enterica 1497 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 315.34Molecular Weight (Monoisotopic): 315.1120AlogP: 3.04#Rotatable Bonds: 3
Polar Surface Area: 72.18Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.87CX Basic pKa: 2.68CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -2.17

References

1. Hammouda MM, Gaffer HE, Elattar KM..  (2022)  Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold.,  13  (10.0): [PMID:36325400] [10.1039/d2md00192f]

Source